AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese

The Role of Artificial Intelligence in Adverse Drug Reaction Monitoring: Current Status and Challenges

Yuge WEI1Ronghao LI2Chenyi SUN3Congmin ZHU2Ting CHEN4Hong YANG1Honglei LIU2( )
Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
Department of Bioengineering, Capital Medical University, Beijing 100069, China
Department of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
Department of Computer Science, Tsinghua University, Beijing 100084, China
Show Author Information

Abstract

Adverse drug reactions (ADRs) significantly impact clinical medication safety. The timely identification and prediction of ADRs rely on the efficient analysis of real-world data, such as electronic health records, social media, and spontaneous reporting databases. In recent years, the rapid advancement of artificial intelligence, particularly large language models, in natural language processing, causal reasoning, and complex data mining has provided new technological means for real-time ADRs monitoring and individualized prediction. This paper summarizes the latest research achievements in AI-driven ADRs monitoring. Focusing on diverse data sources, including structured databases and electronic health records, it elaborates on the advantages andchallenges of AI in ADRs event extraction, relationship identification, causal analysis, and risk prediction. The aim is to provide a theoretical reference for constructing more intelligent and efficient ADRs monitoring systems.

CLC number: R969.3; TP29 Document code: A Article ID: 1674-9081(2025)06-1363-08

References

【1】
【1】
 
 
Medical Journal of Peking Union Medical College Hospital
Pages 1363-1370

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
WEI Y, LI R, SUN C, et al. The Role of Artificial Intelligence in Adverse Drug Reaction Monitoring: Current Status and Challenges. Medical Journal of Peking Union Medical College Hospital, 2025, 16(6): 1363-1370. https://doi.org/10.12290/xhyxzz.2025-0758

1237

Views

29

Downloads

0

Crossref

1

Scopus

1

CSCD

Received: 31 July 2025
Accepted: 28 October 2025
Published: 20 November 2025
© 2025 Medical Journal of Peking Union Medical College Hospital